GO
Loading...

Pharmaceuticals

More

  • Valeant complains to regulators about Allergan Monday, 21 Jul 2014 | 7:07 AM ET
    Michael Pearson, CEO of Valeant Pharmaceuticals.

    Valeant has complained to regulators that claims made by Allergan to counter a hostile takeover are misleading, sources have told CNBC.

  • FedEx indictment shouldn't hurt shares, pro says Friday, 18 Jul 2014 | 4:41 PM ET
    A FedEx logo on a delivery truck

    FedEx's indictment for shipping packages from illegal online pharmacies isn't hurting shares, which makes sense to one analyst.

  • July 18- Valeant Pharmaceuticals Inc moved on Friday to blunt a key criticism by takeover target Allergan Inc of its Bausch+ Lomb business by releasing data showing strong sales growth.

  • July 18- Valeant Pharmaceuticals Inc moved on Friday to blunt a key criticism by takeover target Allergan Inc of its Bausch+ Lomb business by releasing data showing strong sales growth.

  • AbbVie, Shire agree on $55B combination Friday, 18 Jul 2014 | 6:43 AM ET

    The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home. But the new company will be controlled by shareholders of North Chicago, Illinois- based AbbVie, who will own about 75 percent of the new company's stock.

  • FedEx slapped with US charges over online drugs Friday, 18 Jul 2014 | 6:26 AM ET
    FedEx workers unload packages from a delivery truck in San Francisco, California.

    FedEx was indicted for shipping packages from illegal online pharmacies despite repeated warnings from U.S. drug enforcement officials.

  • Shire, Abbvie to announce merger shortly?     Friday, 18 Jul 2014 | 4:30 AM ET

    Surani Fernando, assistant editor at Biopharm Insight, says the market sees the latest Abbvie's takeover bid for Shire as fair and that the announcement of a merger should soon be made.

  • BEIJING, July 17- China will publicly prosecute a foreign couple linked to drugmaker GlaxoSmithKline Plc on charges of illegally obtaining private information, state media said. The announcement comes after the United States and Britain raised concerns about access to the trial.

  • UPDATE 2-Gambro acquisition boosts Baxter's sales Thursday, 17 Jul 2014 | 1:30 PM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.

  • July 17- Shire Plc and U.S. drugmaker Abbvie Inc plan to announce a $53 billion merger as soon as Friday morning, two people said on Thursday. Dublin- based Shire, which sells drugs for rare diseases, said earlier this week it was ready to recommend a deal to shareholders after AbbVie increased its offer.

  • July 17- Shire Plc and U.S. drugmaker Abbvie Inc plan to announce a $53 billion merger as soon as Friday morning, two people said on Thursday. Dublin- based Shire, which sells drugs for rare diseases, said earlier this week it was ready to recommend a deal to shareholders after AbbVie increased its offer.

  • BEIJING, July 17- China will try in public a foreign couple linked to drugmaker GlaxoSmithKline Plc on charges of illegally obtaining private information, state media said, after the United States and Britain raised concerns about access to the trial.

  • Paying for diabetes pandemic     Thursday, 17 Jul 2014 | 8:49 AM ET

    Lars Sorensen, Novo Nordisk CEO, explains why the Affordable Care Act isn't affordable for people with diabetes.

  • UPDATE 1-Medical products boost Baxter's sales Thursday, 17 Jul 2014 | 8:33 AM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly earnings and revenue, helped by surging sales in its medical products division. Net adjusted income rose to $692 million, or $1.26 per share in the second quarter ended June 30, from $639 million, or $1.16 per share, a year earlier.

  • ZURICH, July 17- Swiss drugmaker Novartis posted a quarterly rise in sales that missed expectations and said it would focus on eking out gradual cost savings to boost margins as it prepares a radical business overhaul.

  • Novartis cites momentum in 3 percent profit rise Thursday, 17 Jul 2014 | 2:07 AM ET

    GENEVA— Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products.

  • The billionaire investors, who have been at odds over nutrition and diet company Herbalife, made up in public on Wednesday, ending a decade long feud that exploded on cable television 18 months ago.

  • Studies see new risks for cholesterol drug niacin Wednesday, 16 Jul 2014 | 5:10 PM ET

    New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use. Those details are in this week's New England Journal of Medicine.

  • NEW YORK, July 16- Billionaire investor John Paulson on Wednesday called Valeant Pharmaceuticals International Inc a "very serious acquirer" and predicted that Allergan Inc cannot rebuff the drug maker on its own.

  • *Three ex-GSK staff seek labour arbitration in Shanghai. BEIJING/ SHANGHAI, July 16- Three former Chinese employees of GlaxoSmithKline PLC, which is embroiled in a long-running corruption probe in China, are seeking compensation for illegal dismissal from their jobs, a lawyer representing them told Reuters.